Gut/brain axis and the microbiota

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 926-938

  Mayer, Emeran A ^a,b   Tillisch, Kirsten ^a,b,c   Gupta, Arpana ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; AUTISM; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR CHANGE; BRAIN DEVELOPMENT; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; DEPRESSION; HUMAN; INTESTINE FLORA; IRRITABLE COLON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH; ANIMAL; BEHAVIOR; BRAIN; CELL MEMBRANE PERMEABILITY; DIET; EMOTION; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; BEHAVIOR; BRAIN; CELL MEMBRANE PERMEABILITY; DIET; EMOTIONS; GASTROINTESTINAL TRACT; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTESTINAL MUCOSA; MICROBIOTA; PITUITARY-ADRENAL SYSTEM;

EID: 84924085783     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76304     Document Type: Review

References (140)

1. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12(8):453-466.
2. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009;6(5):306-314.
3. Cryan JF, Dinan TG. Mind-Altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-712.
4. Mayer EA, Padua D, Tillisch K. Altered brain-gut axis in autism: Comorbidity or causative mechanisms? Bioessays. 2014;36(10):933-939.
5. de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev. 2012;70(suppl 1):S45-S56.
6. Park AJ, et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil. 2013;25(9):733-e575.
7. Amaral FA, et al. Co mmensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A. 2008;105(6):2193-2197.
8. Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr. 2011;35(5 suppl):14S-20S.
9. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and path ophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303(7):G775-G785.
10. Matricon J, et al. Review a rticle: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012;36(11-12):1009-1031.
11. Simren M, et al. Intestinal microbio ta in functional bowel disorders: a Rome foundation report. Gut. 2013;62(1):159-176.
12. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313-323.
13. Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305(8):G529-G541.
14. Hughes PA, Zola H, Penttila IA, Blackshaw LA, Andrews JM, Krumbiegel D. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol. 2013;108(7 ):1066-1074.
15. Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol. 2013;13(6):935-940.
16. Valdez-Morales EE, et al. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol. 2013;108(10):1634-1643.
17. Forsythe P, Kunze WA. Voices from within: gut microbes and the CNS. Cell Mol Life Sci. 2013;70(1):55-69.
18. Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology. 2012;37(9):1369-1378.
19. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-312.
20. Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterol Motil. 2012;24(5):405-413.
21. Alco ck J, Maley CC, Aktipis CA. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays. 2014;36(10):940-949.
22. Stilling RM, D inan TG, Cryan JF. Microbial genes, brain & behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014;13(1):69-86.
23. Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146(6):1500-1512.
24. Ford AC, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and ch ronic idiopathic constipation: systematic review and meta-Analysis. Am J Gastroenterol. 2014;109(10):1547-1561.
25. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11(8):497-505.
26. De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol. 2014;592( pt 14):2989-2997.
27. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720-726.
28. Stilling RM, Bordenstein SR, Dinan TG, Cryan JF. Friends with social benefits: host-microbe interactions as a driver of brain evolution and development? Front Cell Infect Microbiol. 2014;4:147.
29. Reeves RR. Ciprofloxacin-induced psychosis. Ann Pharmacother. 1992;26(7-8):930-931.
30. Weis S, Karagulle D, Kornhuber J, Bayerlein K. Cotrimoxazole-induced psychosis: a case report and review of literature. Pharmacopsychiatry. 2006;39(6):236-237.
31. Tillisch K,et al Consumption of fermented milk product with probiotic modulates brain activity Gastroenterology. 2013, 144, 7, 1394-1401.
32. Ahluwalia V, et al. Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implic ations for the gut-liver-brain axis. Metab Brain Dis. 2014;29(4):1017-1025.
33. de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics. 2013;131(2):e550-e558.
34. Rezzi S, et al. Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res. 2007;6(11):4469-4477.
35. Bercik P, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(2):599-609.
36. Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013;16(3):240-245.
37. Sudo N, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-Adrenal system for stress response in mice. J Physiol. 2004;558(pt 1):263-275.
38. Clarke G, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013;18(6):666-673.
39. Diaz Heijtz R, et al. Norm al gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047-3052.
40. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and c entral neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23(3):255-264.
41. Bercik P, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23(12):1132-1139.
42. Bravo JA, et al. Ingestion of Lactobacillus strain regulates emotional behavior and cen tral GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050-16055.
43. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effec ts of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170(4):1179-1188.
44. Crumeyrolle-Arias M, et al. Absence of the gut microbiota enhances a nxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology. 2014;42:207-217.
45. Savignac HM, Kiely B, Dinan TG, Cryan JF. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil. 2014;26(11):1615-1627.
46. Schroeder FA, Lin CL, Crusio WE, Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry. 2007;62(1):55-64.
47. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43(2):164-174.
48. Arseneault-Breard J, et al. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms restores intestinal permeability in a rat model. Br J Nutr. 2012;107(12):1793-1799.
49. Ait-Belgnaoui A, et al. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut. 2006;55(8):1090-1094.
50. Eutamene H, et al. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr. 2007;137(8):1901-1907.
51. Rousseaux C, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007;13(1):35-37.
52. Ma X,Mao YK,Wang B,Huizinga JD,Bienenstock J,Kunze W Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimul i Am J Physiol Gastrointest Liver Physiol. 2009 296 4, G868-G875.
53. Kunze WA, et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med. 2009;13(8B):2261-2270.
54. Duca FA, Swartz TD, Sakar Y, Covasa M. Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One. 2012;7(6):e39748.
55. Vijay-Kumar M, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328(5975):228-231.
56. Tanida M, Yamano T, Maeda K, Okumura N, Fukushima Y, Nagai K. Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity blood pressure in urethane-Anesthetized rats. Neurosci Lett. 2005;389(2):109-114.
57. Swartz TD, Duca FA, de Wouters T, Sakar Y, Covasa M. Up-regulation of intestinal type 1 taste receptor 3 sodium glucose luminal transporter-1 expre ssion increased sucrose intake in mice lacking gut microbiota. Br J Nutr. 2012;107(5):621-630.
58. Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. Microbiota is essential for social development in the mouse. Mol Psychiatry. 2014;19(2):146-148.
59. de Theije CG, et al. Intestinal inflammation in a murine model of autism spectrum disorders. Brain Behav Immun. 2014;37:240-247.
60. Hsiao EY, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451-1463.
61. Aa gaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6(237):237ra65.
62. Fish EW, et al. Epigenetic progra mming of stress responses through variations in maternal care. Ann N Y Acad Sci. 2004;1036:167-180.
63. Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci. 2001;24:1161-1192.
64. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-fre e mice. Proc Natl Acad Sci U S A. 2007;104(3):979-984.
65. Bäckhed F, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718-15723.
66. Braniste V, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158.
67. Verdu EF, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006;55(2):182-190.
68. Bercik P, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139(6):2102-2112.
69. Messaoudi M, Violle N, Bisson JF, Desor D, Javelot H, Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2011;2(4):256-261.
70. Neufeld KA, Kang N, Bienenstock J, Foster JA. Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol. 2011;4(4):492-494.
71. Davari S, Talaei SA, Alaei H, Salami M. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience. 2013;240:28 7-296.
72. Gareau MG, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut. 2011;60(3):307-317.
73. Gilbert JA, Krajmalnik-Brown R, Porazinska D L, Weiss SJ, Knight R. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell. 2013;155(7):1446-1448.
74. Maes M, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012;10:66.
75. Wall R, et al. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the compositi on of murine brain fatty acids gut microbiota. Am J Clin Nutr. 2012;95(5):1278-1287.
76. Nishino R, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment con firmed by culture-based methods. Neurogastroenterol Motil. 2013;25(6):521-528.
77. Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24(6):503-512.
78. Julio-Pieper M, Bravo JA, Aliaga E, Gotteland M. Review article: intestinal barrier dysfunction and central nervo us system disorders-A controversial association. Aliment Pharmacol Ther. 2014;40(10):1187-1201.
79. Resta SC. Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol. 2009;587(pt 17):4169-4174.
80. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 2010;298(6):G807-G819.
81. Clarke G, O'Mahony SM, Dinan TG, Cryan JF. Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour. Acta Paediatr. 2014;103(8):812-819.
82. Bailey MT, Coe CL. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol. 1999;35(2):146-155.
83. Bailey MT, Lubach GR, Coe CL. Prenatal stress alters bacterial colonization of the gut in infant monkeys. J Pediatr Gastroenterol Nutr. 2004;38(4):414-421.
84. O'Mahony SM, et al. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience. 2014;277:885-901.
85. Cox LM, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158(4):705-721.
86. Ladd C O, Huot RL, Thrivikraman KV, Nemeroff CB, Plotsky PM. Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-Adrenal axis following neonatal maternal sep aration. Biol Psychiatry. 2004;55(4):367-375.
87. Coutinho SV, et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gast rointest Liver Physiol. 2002;282(2):G307-G316.
88. O'Mahony SM, et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illne sses. Biol Psychiatry. 2009;65(3):263-267.
89. Schwetz I, et al. Corticotropin-releasing factor receptor 1 mediates acute delayed stress-induced visceral hyperalgesia in maternally separated Long-Ev ans rats. Am J Physiol Gastrointest Liver Physiol. 2005;289(4):G704-G712.
90. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology. 2002;122(7):2032-2048.
91. Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2001;280(4):G519-G524.
92. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 2001;49(12):1023-1039.
93. Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. St ressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun. 2010;78(4):1509-1519.
94. Tannock GW, Savage DC. In fluences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect Immun. 1974;9(3):591-598.
95. Bailey MT,Dowd SE,Galley JD,Hufnagle AR,Allen RG,Lyte M Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation Brain Behav Immun. 2011, 25, 3, 397-407.
96. Collins SM , Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136(6):2003-2014.
97. Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil. 2013;25(9):713-719.
98. Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLos Pathog. 2013;9(11):e1003726.
99. Bra vo JA, et al. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol. 2012;12(6):667-672.
100. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007;61(3):355-361.
101. Bajaj JS, et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLos One. 2013;8(4):e60042.
102. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47(6):861-869.
103. Van Feliu s ID, et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil. 2003;15(3):267-276.
104. Lembo A, Camilleri M. Chronic constipation. New Engl J Med. 2003;349(14):1360-1368.
105. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhi biting abdominal pain and diarrhea. Am J Gastroenterol. 2001;96(5):1499-1506.
106. Macfarlane S, Dillon JF. Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol. 2007;102(5):1187-1196.
107. Alonso C, et al. Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology. 2008;135(1):163-172.
108. Groot J, Bijlsma P, Van Kalkeren A, Kiliaan A, Saunders P, Perdue M. Stress-induced decrease of the intestinal barrier function. The role of muscarinic receptor activation. Ann N Y Acad Sci. 2000;915:237-246.
109. Jacob C, et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-Activated receptor 2 and beta-Arrestins. J Biol Chem. 2005;280(36):31936-31948.
110. Kiliaan AJ, et al. Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am J Physiol. 1998;275(5 pt 1):G1037-G1044.
111. Soderhol m JD, Yates DA, Gareau MG, Yang PC, MacQueen G, Perdue MH. Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am J Physiol Gastrointest Liver Physiol. 2002; 283(6):G1257-G1263.
112. Yates DA, Santos J, Söderholm JD, Perdue MH. Adaptation of stress-induced mucosal pathophysiology in rat colon involves opioid pathways. Am J Physiol Gastrointest Liver Physiol. 2001;281(1):G124-G128.
113. Keita AV, Soderholm JD. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil. 2010;22(7):718-733.
114. Lyte M, Freestone PPEE. Microbial Endocrinology: Interkingdom Signaling In Health Disease. New York, New York, USA: Springer Publishers; 2010.
115. Santos J, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology. 1998;114(4):640-648.
116. Stephens RL,Tache Y Intracisternal injection of a TRH analogue stimulates gastric luminal serotonin release in rats Am J Physiol. 1989, 256(2 pt 1, G377-G383.
117. Yang H, Stephens RL, Tache Y. TRH analogue microinjected into specific medullary nuclei stimulates gastric serotonin secretion in rats. Am J Physiol. 1992;262(2 pt 1):G216-G222.
118. Alverdy J, et al. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg. 2000;232(4):480-4 89.
119. Hughes DT, Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol. 2008;6(2):111-120.
120. Lyte M. Microbial endocrin ology and infectious disease in the 21st century. Trends Microbiol. 2004;12(1):14-20.
121. Cogan TA, et al. Norepinephrine increases the pathogenic potential of Campylobacter jejuni. Gut. 2007;56(8):1060-1065.
122. Wikoff WR, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009;106(10):3698-3703.
123. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221-12 27.
124. Smith PM, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569-573.
125. Vinolo MA, et al. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One. 2011;6(6):e21205.
126. Layden BT, Angueira AR, Brodsky M, Durai V, Lowe WL Jr. Short chain fatty acids and their receptors: new metabolic targets. Transl Res. 2013;161(3):131-140.
127. Nepelsk a M, et al. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. PLoS One. 2012;7(12):e52869.
128. Ganapathy V, Thangaraju M , Prasad PD, Martin PM, Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol. 2013;13(6):869-874.
129. Nohr MK, et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology. 2013;154(10):3552-3564.
130. Soderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol. 2001;280(1):G7-G13.
131. Leclercq S, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014;111(42):E4485-E4493.
132. Iyer LM, Aravind L, Coon S L, Klein DC, Koonin EV. Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role? Trends Genet. 2004;20(7):292-299.
133. Jalanka-Tuovinen J, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut. 2014;63(11):1737-1745.
134. Naseribafrouei A, et al. Correl ation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26(8):1155-1162.
135. Scheperjans F, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype [published online ahead of print December 5, 2014]. Mov Disord. doi:10.1002/mds.26069.
136. Ursell LK, et al. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology. 2014;146(6):1470-1476.
137. Costello EK, Lauber CL, Hamady M, Fierer N, Gordo n JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326(5960):1694-1697.
138. Lozupone CA, et al. Meta-Analyses of studies of the human microbiota. Genome Res. 2013;23(10):1704-1714.
139. Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain dis orders. Trends Mol Med. 2014;20(9):509-518.
140. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011;9(4):279-290.